Immunotherapy of Neuromyelitis Optica
Joint Authors
Bienia, Benjamin
Balabanov, Roumen
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-12-25
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that affects the optic nerves and spinal cord resulting in visual impairment and myelopathy.
There is a growing body of evidence that immunotherapeutic agents targeting T and B cell functions, as well as active elimination of proinflammatory molecules from the peripheral blood circulation, can attenuate disease progression.
In this review, we discuss the immunotherapeutic options and the treatment strategies in NMO.
We also analyze the pathogenic mechanisms of the disease in order to provide recommendations regarding treatments.
American Psychological Association (APA)
Bienia, Benjamin& Balabanov, Roumen. 2013. Immunotherapy of Neuromyelitis Optica. Autoimmune Diseases،Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-495048
Modern Language Association (MLA)
Bienia, Benjamin& Balabanov, Roumen. Immunotherapy of Neuromyelitis Optica. Autoimmune Diseases No. 2013 (2013), pp.1-7.
https://search.emarefa.net/detail/BIM-495048
American Medical Association (AMA)
Bienia, Benjamin& Balabanov, Roumen. Immunotherapy of Neuromyelitis Optica. Autoimmune Diseases. 2013. Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-495048
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-495048